News and Resources

  • Event

    European Cancer Summit 2024

    20 - 21 November 2024, Radisson Collection Hotel, Grand Place Brussels (and Virtual)

    United Against Cancer: Forging New Frontiers


    The European Cancer Summit 2024 will once again unite the cancer community in accelerating efforts against a most relentless disease. Experts, patients and policymakers will explore new innovative solutions to pressing challenges faced by healthcare systems across Europe and propose new opportunities in cancer research.


    This year’s European Cancer Summit takes place on 20 & 21 November, in Brussels & online.  


    The European Cancer Summit will be followed by an exclusive Showcase Event for the smartCARE and PROTECT-EUROPE projects on 22 November, at the same venue. Find out more. 

    Read more
  • Event

    Community 365 Roundtable on EU HTA Cooperation

    08 October 2024, Virtual

    On Tuesday 8 October from 15:00-17:30 CEST, the 2024 ECO Community 365 Roundtable series will continue with a spotlight placed on the issue of ‘EU HTA Cooperation’.


    More information will be published here soon.

    Read more
  • Event

    Community 365 Roundtable on Time to Treatment

    02 July 2024, Virtual

    On Tuesday 2 July from 16:00-18:30 CEST, the 2024 ECO Community 365 Roundtable series will continue with a spotlight placed on the issue of ‘Time to Treatment’. The discussion will investigate the level to which patients are experiencing unnecessary and concerning levels of delay across the cancer care continuum – from a cancer being detected, to diagnosed, to treated. This includes examining delays across different European regions and tumour types, identifying factors contributing to the delays, and exploring potential solutions.


    The Roundtable will be co-chaired by Prof Peter Albers, Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ); and Aleksandra Kaczmarek, Public Policy Manager, Digestive Cancers Europe. The event will hear from oncology professionals, patient representatives, technologists, researchers, and health system managers.


    Evaluating the time between cancer diagnosis and treatment is crucial as timely intervention improves survival rates, reduces patient anxiety and enhances treatment efficacy and efficiency. Participants to the roundtable will explore ways to ensure equitable access to care, improve cancer policy on this topic, and accelerate access to innovations in cancer treatment. The conclusions of the discussions will be synthetised in a future Policy Action Report.

    Read more
  • news

    A new network addressing patient needs in times of crisis

    24 June 2024

    In recent years, crises such as the Covid-19 pandemic and the war in Ukraine have had a significant impact on cancer patients, emphasising the need for global collaboration in response. To that end,  the European Cancer Organisation (ECO) has created a new Focused Topic Network on Emergencies and Crises so that the cancer community can better anticipate and prepare for the urgent needs of cancer patients in emergency situations.

    Emergencies Network Image

    The new network brings together participants from more than 150 organisations.

    Mike Morrissey, CEO of the European Cancer Organisation:

    'emergencies announce mikeOur ability to withstand future challenges that will affect cancer patients depend on the preparedness and resilience of our healthcare systems. We are delighted that people of the calibre of Mark and Jacek have stepped up to lead this new focused topic network, particularly as we see more and more challenges to cancer patients emerging in conflict, crises and emergency situations.'

    Dr Julie Gralow, Chief Medical Officer of the American Society of Clinical Oncology (ASCO), one of the partners in this new network:

    emergencies announce julie'Since the early days of the war in Ukraine, ASCO has been privileged to collaborate with the European Cancer Organisation and its members and partners to respond to the crisis.  We have seen what collective action can do, and in turn we have all learned much from this experience. Regrettably, emergencies and crises will continue to confront the global cancer community - but if we are able to learn from our experiences and work collectively, we can mitigate their effects for the betterment of patients with cancer around the world.'

    Prof Mark Lawler, Queen’s University Belfast, UK, and network Co-Chair:   

    'emergencies announce markWe cannot stand by – we must stand shoulder to shoulder with our cancer patients and our colleagues.   We need to be proactive, not reactive. We need to deliver robust “on the ground” solutions with the urgency that is required to make a real difference to cancer patients and cancer health systems, locally, nationally and globally. This network will position us to do just that.'

    Prof Jacek Jassem, Medical University of Gdansk, Poland, and network Co-Chair:

    emergencies announce jacek'As a resident of a country neighbouring Ukraine, these issues are very close to my heart. Oncology is a particular case because harmed care will have irreversible consequences. Everything must be done to preserve its continuity in all emergency areas. International organisations such as ECO have an essential role to play here. This is our moral obligation.'

    Gilliosa Spurrier-Bernard, Co-Chair of ECO’s Patient Advocacy Committee and Co-Chair of ECO’s European Cancer Summit 2024:

    emergencies announce gilly‘Patients suffer from the state of poly-crisis that our health communities endure from climate change, epidemics, conflict etc. Being able to develop strategies that pre-empt the impact of these on cancer patients and building resilience and adaptability into our health systems is essential for cancer outcomes. Patient Organisations are keen to be at the centre of developing strategies and solutions to mitigate the impact of an unstable world on patients. I am happy that there will be a session developed by the Emergency and Crisis Network at the European Cancer Summit 2024 in Brussels and online.’

    Tackling future emergencies and crises requires a team effort. The more united we are, the more resilient we are. Thus, we welcome new partner organisations to join this network to prepare our medical systems for the unpredictable.

    For more details of ECO’s Focused Topic Networks, please visit the dedicated webpage.

    Read more
  • news

    New Council Recommendation on Vaccine-Preventable Cancers

    21 June 2024


    The Council of the European Union has adapted a groundbreaking set of recommendations to increase vaccination rates against both the human papillomavirus (HPV) and hepatitis B virus (Hep B) and combating cancers caused by these two viruses. The measures were agreed upon  today on during a meeting of the EPSCO (Employment, Social Policy, Health and Consumer Affairs Council) in Brussels, and are crucial for advancing our efforts to prevent cancer across Europe.

    Key recommendations to member states include:

    • Introducing 19 measures to boost HPV and HepB vaccination uptake by removing structural barriers for disadvantaged and high-risk groups
    • Expanding access to vaccination by providing the service free of charge or fully reimbursable
    • Enhancing data-driven decision-making for vaccination programmes
    • Ensuring the European Centre for Disease Prevention and Control will display national data on HPV coverage rates in EU member states on a dedicated dashboard by the end of the year
    • Promoting a target for the percentage of boys to be vaccinated against HPV by 2030.
    • Focusing on high-risk groups for HepB and reaching the 2030 goal of hepatitis elimination through 95% vaccination coverage

    These measures are part of the broader Europe's Beating Cancer Plan and effort to reduce the vaccine-preventable cancers. Daniel Kelly and Margaret Stanley, co-chairs of the ECO HPV and Hep B Action Network, had this to say:

    'The newly published Council Recommendation is welcome and shows a clear commitment from Member States to overcome current barriers and expand access to HPV and HBV vaccination. However, more can still be done, especially to increase HPV coverage by establishing a target for the vaccination of boys.' - Daniel Kelly

    'Leveraging data-driven decision-making and setting clear vaccination targets represents a huge step forward. These recommendations can enhance our efforts to prevent vaccine-preventable cancers and protect future generations.’ – Margaret Stanley

    These recommendations are crucial for advancing our efforts in cancer prevention across Europe. Find the full adopted document here.

    Read more
  • reports

    Cancer Care for the LGBTQI+ Community: Addressing Inequalities

    June 2024

    In the wake of increasing recognition of inequalities affecting healthcare, addressing inequalities in oncology for LGBTQI+ identities is a topic that has only recently received attention within the healthcare sphere. This report presents outcomes from a workshop organised by the Inequalities Network of the European Cancer Organisation, dedicated to exploring and addressing the inequalities faced by LGBTQI+ individuals within the realm of oncology.

    Read more
  • news

    New Report Identifies Need for Inclusive Cancer Care Policies to Address Specific Healthcare Needs and Inequalities for LGBTQI+ Community

    20 June 2024

    To mark Pride Month, The European Cancer Organisation (ECO), through its Inequalities Network, has released a timely report on reducing disparities in cancer care faced by the LGBTQI+ community. The report, titled ‘Cancer Care for the LGBTQI+ Community: Addressing Inequalities’, is the result of a comprehensive workshop involving clinicians, researchers, policymakers, and LGBTQI+ advocates.

    Read more
  • news

    Addressing Inequalities in Oncology for LGBTQI+ People

    30 May 2024

    Inequities in cancer care persist for LGBTQI+ individuals, affecting their access to prevention, diagnosis, treatment, and survivorship services. This is shown by the recent publication of the European Union Agency for Fundamental Rights, “LGBTIQ at a crossroads: progress and challenges”, which has shown that compared to general population, not only LGBTQI+ people have lower rates of mammography (10% vs 36% of general population) and cervical uptake (27% vs 36% of general population), but they also showed higher rates of cancer diagnoses in the previous year, especially for Intersex people who in the year previous to the survey, had showed a cancer diagnosis rate of 2%, compared to the 0.6% of the general population in the same period.

    Read more
  • news

    More Focused Topic Network Meetings Scheduled for June 2024

    28 May 2024

    The following ECO Focused Topic Network meetings will take place in June:

    • Emergencies and Crises Network - 13 June, 9:00-10:30 CEST
    • Survivorship and Quality of Life Network - 17 June, 9:30-11:00 CEST
    • Digital Health Network - 18 June, 10:15-11:45 CEST
    Read more